Tirzepatide 20mg (R&D Only) stands as a premier GLP-1 research peptide, engineered for high-impact studies. Supplied by Med Express Pharmacy in specialized pre-filled pens, this format ensures streamlined, controlled use within R&D environments. Each multi-dose device is built for maximum stability and repeatable precision without the hassle of manual reconstitution.

Selecting the Right Kit for Your Study

The "20mg" designation indicates the total peptide volume per device. To choose the right fit, simply tally your total planned doses:

• 20mg Tirzepatide Pen: Optimized for initial titration or early-phase research.
  • Best for 2.5mg and 5mg doses.
  • Provides roughly an 8-week supply.
• 40mg Tirzepatide Pen: Engineered for long-term or high-intensity protocols.
  • Supports doses from 2.5mg up to 10mg.
  • Provides a 12–16 week supply, depending on frequency.

Seamless Transitions

For researchers transitioning from Mounjaro (MJ), Alluvi Tirzepatide allows for a direct continuation. You can maintain your established dosing schedule without the need to restart or re-titrate.

The Alluvi Advantage

• Turn-Dial Precision: Select your exact dose with a simple twist—no manual measuring required.
• Integrity Focused: Professionally buffered and sealed to ensure compound stability.
• Efficiency: Pre-filled pens minimize handling errors and maximize lab consistency.

Research Tip: For optimal results in injection studies, allow the device to reach room temperature before use to ensure a smoother delivery.

Summary:

• 20mg Pen: Your go-to for low-dose or introductory research.
• 40mg Pen: The professional choice for advanced dosing and extended studies.